# Alliance Pharma plc 22.0% potential upside indicated by Peel Hunt Limited

- Link: https://www.directorstalkinterviews.com/alliance-pharma-plc-22.0-potential-upside-indicated-by-peel-hunt-limited/4121129064
- Published: 2023-10-10T12:46:28+01:00
- Author: Charlotte Edwards

**Alliance Pharma plc** with ticker (LON:APH) now has a potential upside of 22.0%
according to Peel Hunt Limited.
Peel Hunt Limited set a target price of 53 GBX for
the company, which when compared to the Alliance Pharma plc share price of 43 GBX
at opening today (10/10/2023) indicates a potential upside of 22.0%. Trading has
ranged between 34 (52 week low) and 73 (52 week high) with an average of 2,467,611
shares exchanging hands daily. The market capitalisation at the time of writing 
is £224,289,716.Alliance Pharma PLC is a United Kingdom-based international consumer
healthcare company. The principal activity of the Company is to act as a holding
company. The principal activity of the Company is the acquisition, marketing and
distribution of consumer healthcare and pharmaceutical products. Its segments are
strategic business units that represent different parts of the overall product portfolio,
these being Consumer Healthcare brands and Prescription Medicines. Its Consumer 
Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair,
Vamousse, and other consumer healthcare brands. Its Prescription Medicines include
Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products
include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch
Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare
brands and Prescription Medicines, which are sold around the world in more than 
100 countries.

Share on: